Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Organigram Global Inc.NASDAQ: OGI

Income Tax Expense · Q2 FY2026 · quarter ended Mar 2026

Income tax expense turns positive

Q2 FY2026 income tax expense was CA$0, compared with -CA$106K a year earlier. Trailing-twelve-month income tax expense was -CA$13.66M.

Context

  • Income tax expense amounted to 5.3% of revenue in FY2025, up 5.3 pp from a year earlier.
  • Income tax expense increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly income tax expense holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of -CA$3.42M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearSep 2025
-CA$9.89M— YoY
LTMMar 2026
-CA$13.66M-29804.3% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+100.0%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

CAD · from the income statement

Latest · FY2025
(9.89M) CAD
Year-over-year change
—

Income Tax Expense vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -29804.3% is the lowest of 7, against a peer median of -19.1%.
  • Income tax expense amounts to 5.0% of revenue for OGI, versus a peer median of 0.5%.
OGI Competitors
Income Tax Expense for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INFUInfuSystem Holdings, Inc.LTM Mar 2026$3.88M USD+13.3%+229.2%2.7%
ELMDElectromed, Inc.LTM Mar 2026$3.47M USD+41.9%+58.3%4.8%
ACBAurora Cannabis Inc.LTM Mar 2026CA$2.93M CAD-36.6%-49.7%0.9%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$413K USD——0.3%
DERMJourney Medical CorporationLTM Mar 2026$60K USD-1.6%-1.6%0.1%
IVAInventiva S.A.FY2025€22K EUR-93.0%—0.5%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$0 USD——0.0%
HSDTSolana CompanyLTM Mar 2026$0 USD——0.0%
RNACCartesian Therapeutics, Inc.LTM Mar 2026-$9.19M USD-3303.1%—517.9%
OGIOrganigram Global Inc.LTM Mar 2026-CA$13.66M CAD-29804.3%—5.0%
Peer median (excluding OGI) —-19.1%+28.4%0.5%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.